December 1, 2022

Volume XII, Number 335

Advertisement

December 01, 2022

Subscribe to Latest Legal News and Analysis

November 30, 2022

Subscribe to Latest Legal News and Analysis

November 29, 2022

Subscribe to Latest Legal News and Analysis

November 28, 2022

Subscribe to Latest Legal News and Analysis

Intellectual Property, Patent, Trademark and Copyright Law News

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

For hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Date Title Organization
31
Oct
Patent Considerations and the Metaverse ArentFox Schiff LLP
31
Oct
Choosing Between a §371 National Stage Entry and a Bypass Continuation for Your U.S. Patent Application von Briesen & Roper, s.c.
31
Oct
File Format Fracas: USPTO Pushes Switch from PDF to DOCX von Briesen & Roper, s.c.
31
Oct
USPTO Ideas For Bolstering Robustness And Reliability Of Patents Demand Attention And Stakeholder Input Foley & Lardner LLP
31
Oct
King Semi Settles Chinese Criminal Trade Secret Case for 60 Million RMB Schwegman, Lundberg & Woessner, P.A.
30
Oct
China to Add Statement of Use Requirement for Trademarks? Schwegman, Lundberg & Woessner, P.A.
30
Oct
NCAA Guidance Allows Schools to Engage in Certain Name, Image, and Likeness Activities With Student-Athletes, NIL Entities Jackson Lewis P.C.
30
Oct
China to Release Revised Implementing Regulations of the Patent Law and the Guidelines for Patent Examination By End of December 2022 Schwegman, Lundberg & Woessner, P.A.
28
Oct
D.C. Employers: Have You Complied With the Non-Compete Clarification Amendment Act? Epstein Becker & Green, P.C.
28
Oct
2022 NFT Litigation Roundup Foley & Lardner LLP
28
Oct
Who Really Owns Your Business’s Trade Mark? Federal Court of Australia Confirms that A Trade Mark Can Be Registered in The Name of A Company’s Sole Director and Shareholder K&L Gates
27
Oct
One Bad Apple Won’t Spoil the Rest of the Bunch’s Ability to Fairly Compete in Matthews International Corp. v. Lombardi Sheppard, Mullin, Richter & Hampton LLP
27
Oct
Does Not Compute: Faster Processes Aren’t Enough for Subject Matter Eligibility McDermott Will & Emery
27
Oct
Color Me Unsurprised: No Preclusion of Plaintiff’s Claims McDermott Will & Emery
27
Oct
Establishing Indefiniteness Requires More Than Identifying “Unanswered Questions” Part II McDermott Will & Emery
26
Oct
Episode 50: TSLE Celebrates 50 [PODCAST] Greenberg Traurig, LLP
25
Oct
The Developing “Avoided Costs” Remedy in Trade Secret Litigation Sheppard, Mullin, Richter & Hampton LLP
21
Oct
Amazon and GE Team Up Against Counterfeiters Norris McLaughlin P.A.
20
Oct
Common Diligence Issues for Startup and Emerging Technology Companies Foley & Lardner LLP
20
Oct
The Name of the Game Is the Claims, Even if Specification Is Shared McDermott Will & Emery

Pages

Advertisement
Advertisement
Advertisement